Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
 CDC's Issues in Healthcare SettingsLink to DHQP Home PageLink to Issues in Healthcare Settings  Index
Main Topics
About DHQP
Antimicrobial Resistance
Bloodborne
Pathogens
Child Care
Dialysis
Guidelines &
Recommendations
Infectious Diseases
Laboratory
Occupational Health
Outbreaks
Sterilization and Disinfection
Surveillance
Training
Antimicrobial Resistance
VISA/VRSA - Vancomycin-Intermediate/Resistant Staphylococcus aureus

 


Topic Categories:
General Information
Prevention and Control
Laboratory Testing and Practices
Scientific Publications
(Epidemiology & Laboratory)

Background/General Information

VISA/VRSA Fact Sheet March 2003
Q&A about VISA/VRSA in the community and in healthcare


Prevention & Control of VISA/VRSA

Health Department and Infection Control Guidance Updated: April 2004 This is a PDF file - Click for Instructions PDF (204KB/16 pages)
Precautions, management and control in healthcare


Interim Guidelines for Prevention and Control July 1997 This is a PDF file - Click for Instructions PDF (164KB)

 

Laboratory Testing and Practices

Laboratory Testing Algorithm Update: April 2004
A sample algorithm that highlights the recommended testing methodologies for detecting VISA/VRSA and actions based on these results.

Laboratory Detection of VISA/VRSA Updated: April 2004
Questions and answers about susceptibility testing, screening, etc. of VISA/VRSA

S.E.A.R.C.H. Confirmatory Reference Testing
A network of voluntary participants who have joined together to report the isolation of S. aureus with reduced susceptibility to vancomycin


Scientific Publications (Epidemiology & Laboratory)

Epidemiology
Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, U.S., 1997-2001. Clin Infec Dis 2003 Leave CDC

Public Health Dispatch: Vancomycin-Resistant Staphylococcus aureus - Pennsylvania, 2002 MMWR October 2002

Staphylococcus aureus Resistant to Vancomycin MMWR July 2002

Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis 2001 Leave CDC

Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999 Leave CDC

Vancomycin-Intermediate Staphylococcus aureus in a Home Health-Care Patient EID Journal 2001

Staphylococcus aureus with Reduced Susceptibility to Vancomycin---Illinois, 1999. MMWR 2000

Staphylococcus aureus with Reduced Susceptibility to Vancomycin Isolated from a Patient with Fatal Bacteremia.
EID Journal 1999

Update: Staphylococcus aureus with Reduced Susceptibility to Vancomycin - U.S., 1997. MMWR 1997 This is a PDF file - Click for Instructions PDF (265KB)

Staphylococcus aureus with Reduced Susceptibility to Vancomycin - U.S. 1997. MMWR 1997 This is a PDF file - Click for Instructions PDF (273KB)

Reduced Susceptibility of Staphylococcus aureus to Vancomycin - Japan 1996. MMWR 1997 This is a PDF file - Click for Instructions PDF (86KB)

Laboratory
Cui L., et al. Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureus J Clin Microbiol. 2003;41: 5-14.

Increasing resistance vancomycin and other glycopeptides in Staphylococcus aureus. EID Journal 2001

Laboratory Capacity to Detect Antimicrobial Resistance, 1998. MMWR 2000

Tenover FC, Lancaster MV, Hill BC, et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 1998;36:1020-7. [Erratum, J Clin Microbiol;36:2167.]

 



DHQP Home |DHQP Index

NCID Home
| CDC Home | CDC Search | CDC Health Topics A-Z

This page developed and maintained by:
Division of Healthcare Quality Promotion
National Center for Infectious Diseases
Centers for Disease Control and Prevention